Climara Patch
Product Images NDC 50419-451

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Climara (NDC 50419-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
FDA Label Image

Patch Diagram (Image 02)

Patch Diagram (Image 02)
FDA Label Image

Fig 1 (Image 03)

Fig 1 (Image 03)
FDA Label Image

Fig 2 (Image 04)

Fig 2 (Image 04)
The given text is a chart showing three numerical values (200, 150, and 100) and two labels for treatment areas (Buttock and Abdomen). The remaining text appears to be a header and/or title and some coordinates for a sampling time chart. Therefore, the text does not provide a useful description.*
FDA Label Image

Fig 3 (Image 05)

Fig 3 (Image 05)
FDA Label Image

Fig 4 (Image 06)

Fig 4 (Image 06)
FDA Label Image

Fig A (Image 07)

Fig A (Image 07)
FDA Label Image

Fig B (Image 08)

Fig B (Image 08)
FDA Label Image

Fig C (Image 09)

Fig C (Image 09)
This text is too short and doesn't provide enough context to generate a description. It simply suggests the existence of a protective backing of some sort.*
FDA Label Image

Fig D (Image 10)

Fig D (Image 10)
FDA Label Image

Fig E (Image 11)

Fig E (Image 11)
This text gives instructions to someone who uses the Climara patch. It advises them to remove the patch carefully but warns not to remove the first sticker.*
FDA Label Image

Fig F (Image 12)

Fig F (Image 12)
FDA Label Image

Fig G (Image 13)

Fig G (Image 13)
FDA Label Image

Fig H (Image 14)

Fig H (Image 14)
FDA Label Image

.025 mg (Image 15)

.025 mg (Image 15)
This is a product description for a transdermal system used to administer the hormone estradiol. The system contains 2 mg of estradiol USP and provides 0.035 mg of estradiol per day. It is applied once a week and contains a copolymer adhesive on a polyethylene backing. The text also includes a warning to keep the product and all drugs out of reach of children.*
FDA Label Image

0.375 (Image 16)

0.375 (Image 16)
FDA Label Image

0.5 Carton (Image 17)

0.5 Carton (Image 17)
FDA Label Image

0.6 Carton (Image 18)

0.6 Carton (Image 18)
This appears to be a product description for a transdermal system for delivering a hormone called estradiol. The system needs to be applied once a week and each system contains 0.55 mg of estradiol. The system uses an adhesive and is made of a copolymer and a polyethylene backing, and it is important to keep it out of reach of children. There is also a warning to read the instructions before use.*
FDA Label Image

0.75 Carton (Image 19)

0.75 Carton (Image 19)
Climara is a transdermal system that contains 7mg of estradiolUS7 per week. It should only be used as a transdermal patch and one patch should be used per week. The package contains 3 components - a polymer matrix, estradiolUS7, and a backing of polyethylene. This medication is not suitable for children.*
FDA Label Image

0.1 Carton (Image 20)

0.1 Carton (Image 20)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.